RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
China Resources Pharmaceutical Group Stock

China Resources Pharmaceutical Group Debt 2024

China Resources Pharmaceutical Group Debt

40,500.83 CNY

Ticker

3320.HK

ISIN

HK0000311099

WKN

A2ATTU

In 2024, China Resources Pharmaceutical Group's total debt was 40,500.83 CNY, a 2.86% change from the 39,373.23 CNY total debt recorded in the previous year.

China Resources Pharmaceutical Group Aktienanalyse

What does China Resources Pharmaceutical Group do?

China Resources Pharmaceutical Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding China Resources Pharmaceutical Group's Debt Structure

China Resources Pharmaceutical Group's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing China Resources Pharmaceutical Group's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to China Resources Pharmaceutical Group’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in China Resources Pharmaceutical Group’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about China Resources Pharmaceutical Group stock

What is the debt of China Resources Pharmaceutical Group this year?

China Resources Pharmaceutical Group has a debt level of 40,500.83 CNY this year.

What was the debt of China Resources Pharmaceutical Group compared to the previous year?

The debt of China Resources Pharmaceutical Group has increased by 2.86% compared to the previous year increased.

What are the consequences of high debt for investors in China Resources Pharmaceutical Group?

High debt can pose a risk for investors of China Resources Pharmaceutical Group, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of China Resources Pharmaceutical Group?

Low debt means that China Resources Pharmaceutical Group has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from China Resources Pharmaceutical Group affect the company?

An increase in debt of China Resources Pharmaceutical Group can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of China Resources Pharmaceutical Group affect the company?

A reduction in debt of China Resources Pharmaceutical Group can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of China Resources Pharmaceutical Group?

Some factors that can influence the debt of China Resources Pharmaceutical Group include investments, acquisitions, operating costs, and revenue development.

Why are the debts of China Resources Pharmaceutical Group so important for investors?

The debts of China Resources Pharmaceutical Group are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can China Resources Pharmaceutical Group take to change the debt?

To change the debt, China Resources Pharmaceutical Group can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does China Resources Pharmaceutical Group pay?

Over the past 12 months, China Resources Pharmaceutical Group paid a dividend of 0.16 CNY . This corresponds to a dividend yield of about 3.63 %. For the coming 12 months, China Resources Pharmaceutical Group is expected to pay a dividend of 0.17 CNY.

What is the dividend yield of China Resources Pharmaceutical Group?

The current dividend yield of China Resources Pharmaceutical Group is 3.63 %.

When does China Resources Pharmaceutical Group pay dividends?

China Resources Pharmaceutical Group pays a quarterly dividend. This is distributed in the months of July, July, October, October.

How secure is the dividend of China Resources Pharmaceutical Group?

China Resources Pharmaceutical Group paid dividends every year for the past 12 years.

What is the dividend of China Resources Pharmaceutical Group?

For the upcoming 12 months, dividends amounting to 0.17 CNY are expected. This corresponds to a dividend yield of 3.84 %.

In which sector is China Resources Pharmaceutical Group located?

China Resources Pharmaceutical Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von China Resources Pharmaceutical Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of China Resources Pharmaceutical Group from 10/30/2024 amounting to 0.01 CNY, you needed to have the stock in your portfolio before the ex-date on 9/12/2024.

When did China Resources Pharmaceutical Group pay the last dividend?

The last dividend was paid out on 10/30/2024.

What was the dividend of China Resources Pharmaceutical Group in the year 2023?

In the year 2023, China Resources Pharmaceutical Group distributed 0.15 CNY as dividends.

In which currency does China Resources Pharmaceutical Group pay out the dividend?

The dividends of China Resources Pharmaceutical Group are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von China Resources Pharmaceutical Group

Our stock analysis for China Resources Pharmaceutical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of China Resources Pharmaceutical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.